Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Occipital Nerve Block vs Acetaminophen/Caffeine for Headache in Pregnancy
NCT03951649Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in Headache (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Number of Participants With Response to Occipital Nerve Block in Pregnancy. Started Feb 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
Headache
Beyond the preview
Go deeper on NCT03951649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03951649.